BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31778857)

  • 1. Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion.
    Dosekova P; Dubiel A; Karlowicz A; Zietkiewicz S; Rydzanicz M; Habalova V; Pienkowski VM; Skirkova M; Han V; Mosejova A; Gdovinova Z; Kaliszewska M; Tońska K; Szymanski MR; Skorvanek M; Ploski R
    Eur J Med Genet; 2020 Apr; 63(4):103821. PubMed ID: 31778857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion.
    Varma H; Faust PL; Iglesias AD; Lagana SM; Wou K; Hirano M; DiMauro S; Mansukani MM; Hoff KE; Nagy PL; Copeland WC; Naini AB
    Eur J Med Genet; 2016 Oct; 59(10):540-5. PubMed ID: 27592148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome.
    Hoff KE; DeBalsi KL; Sanchez-Quintero MJ; Longley MJ; Hirano M; Naini AB; Copeland WC
    PLoS One; 2018; 13(8):e0203198. PubMed ID: 30157269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
    Mukai M; Sugaya K; Matsubara S; Cai H; Yabe I; Sasaki H; Nakano I
    Rinsho Shinkeigaku; 2014; 54(5):417-22. PubMed ID: 24943079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing in family with MNGIE syndrome associated to optic atrophy: Novel homozygous POLG mutation in the C-terminal sub-domain leading to mtDNA depletion.
    Felhi R; Sfaihi L; Charif M; Desquiret-Dumas V; Bris C; Goudenège D; Ammar-Keskes L; Hachicha M; Bonneau D; Procaccio V; Reynier P; Amati-Bonneau P; Lenaers G; Fakhfakh F
    Clin Chim Acta; 2019 Jan; 488():104-110. PubMed ID: 30395865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polg2 is essential for mammalian embryogenesis and is required for mtDNA maintenance.
    Humble MM; Young MJ; Foley JF; Pandiri AR; Travlos GS; Copeland WC
    Hum Mol Genet; 2013 Mar; 22(5):1017-25. PubMed ID: 23197651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment.
    Brañas Casas R; Zuppardo A; Risato G; Dinarello A; Celeghin R; Fontana C; Grelloni E; Gilea AI; Viscomi C; Rasola A; Dalla Valle L; Lodi T; Baruffini E; Facchinello N; Argenton F; Tiso N
    Cell Death Dis; 2024 Apr; 15(4):281. PubMed ID: 38643274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLG2 disease variants: analyses reveal a dominant negative heterodimer, altered mitochondrial localization and impaired respiratory capacity.
    Young MJ; Humble MM; DeBalsi KL; Sun KY; Copeland WC
    Hum Mol Genet; 2015 Sep; 24(18):5184-97. PubMed ID: 26123486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature.
    Borsche M; Dulovic-Mahlow M; Baumann H; Tunc S; Lüth T; Schaake S; Özcakir S; Westenberger A; Münchau A; Knappe E; Trinh J; Brüggemann N; Lohmann K
    Cerebellum; 2024 Apr; 23(2):479-488. PubMed ID: 37085601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.
    Ferraris S; Clark S; Garelli E; Davidzon G; Moore SA; Kardon RH; Bienstock RJ; Longley MJ; Mancuso M; Gutiérrez Ríos P; Hirano M; Copeland WC; DiMauro S
    Arch Neurol; 2008 Jan; 65(1):125-31. PubMed ID: 18195150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma.
    Pagnamenta AT; Taanman JW; Wilson CJ; Anderson NE; Marotta R; Duncan AJ; Bitner-Glindzicz M; Taylor RW; Laskowski A; Thorburn DR; Rahman S
    Hum Reprod; 2006 Oct; 21(10):2467-73. PubMed ID: 16595552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy.
    Ahola S; Isohanni P; Euro L; Brilhante V; Palotie A; Pihko H; Lönnqvist T; Lehtonen T; Laine J; Tyynismaa H; Suomalainen A
    Neurology; 2014 Aug; 83(8):743-51. PubMed ID: 25037205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camptocormia as a Novel Phenotype in a Heterozygous
    Lehmann Urban D; Motlagh Scholle L; Alt K; Ludolph AC; Rosenbohm A
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31991853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.
    Cohen BH; Naviaux RK
    Methods; 2010 Aug; 51(4):364-73. PubMed ID: 20558295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mitochondrial DNA replication machinery and disease.
    Young MJ; Copeland WC
    Curr Opin Genet Dev; 2016 Jun; 38():52-62. PubMed ID: 27065468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mitochondrial implication in a Tunisian patient with Friedreich's ataxia-like.
    Maalej M; Mkaouar-Rebai E; Mnif M; Mezghani N; Ben Ayed I; Chamkha I; Abid M; Fakhfakh F
    Pathol Biol (Paris); 2014 Feb; 62(1):41-8. PubMed ID: 24011957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitochondrial disease and mitochondrial DNA depletion syndromes].
    Huang CC; Hsu CH
    Acta Neurol Taiwan; 2009 Dec; 18(4):287-95. PubMed ID: 20329599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A p.R369G POLG2 mutation associated with adPEO and multiple mtDNA deletions causes decreased affinity between polymerase γ subunits.
    Craig K; Young MJ; Blakely EL; Longley MJ; Turnbull DM; Copeland WC; Taylor RW
    Mitochondrion; 2012 Mar; 12(2):313-9. PubMed ID: 22155748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.
    Del Dotto V; Ullah F; Di Meo I; Magini P; Gusic M; Maresca A; Caporali L; Palombo F; Tagliavini F; Baugh EH; Macao B; Szilagyi Z; Peron C; Gustafson MA; Khan K; La Morgia C; Barboni P; Carbonelli M; Valentino ML; Liguori R; Shashi V; Sullivan J; Nagaraj S; El-Dairi M; Iannaccone A; Cutcutache I; Bertini E; Carrozzo R; Emma F; Diomedi-Camassei F; Zanna C; Armstrong M; Page M; Stong N; Boesch S; Kopajtich R; Wortmann S; Sperl W; Davis EE; Copeland WC; Seri M; Falkenberg M; Prokisch H; Katsanis N; Tiranti V; Pippucci T; Carelli V
    J Clin Invest; 2020 Jan; 130(1):108-125. PubMed ID: 31550240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorders in mitochondrial diseases.
    Tranchant C; Anheim M
    Rev Neurol (Paris); 2016; 172(8-9):524-529. PubMed ID: 27476418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.